Search for: "Pharmaceutical Research and Manufacturers of America" Results 61 - 80 of 410
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Sep 2020, 9:05 pm by Max Masuda-Farkas
Stephen Ubl, president and CEO of Pharmaceutical Research and Manufacturers of America—a drug lobbying group—critiqued the new order as “an irresponsible and unworkable policy” because it relies on how other countries set drug prices. [read post]
25 Aug 2020, 2:24 pm by Colby Pastre
Second is allowing 100 percent expensing for certain industries (pharmaceuticals and robotics) that bring manufacturing back to the United States. [read post]
10 Aug 2020, 9:38 am by David Gallacher and Keeley A. McCarty
It may be safe to assume that when it comes to the active ingredient, “produced” means… well, “produced” – made, created, developed, manufactured – here in the United States of America. [read post]
30 Jul 2020, 9:05 pm by Joshua Burd
A Pharmaceutical Researchers and Manufacturers of America spokesperson reportedly claimed that the industry remains “steadfastly opposed to policies that would allow foreign governments to set prices for medicines in the United States. [read post]
24 Jul 2020, 7:07 pm
It was to explain the different facets of America’s relationship with China, the massive imbalances in that relationship that have built up over decades, and the Chinese Communist Party’s designs for hegemony. [read post]
25 Jun 2020, 9:15 am by Rebecca Tapscott
Birch Bayh; Hans Sauer, the Deputy General Counsel and Vice President for Intellectual Property for the Biotechnology Innovation Organization; Jennifer Gottwald, the Senior Licensing Manager at the Wisconsin Alumni Research Foundation (WARF);  and David Korn, the Vice President of Intellectual Property (IP) and Law for the Pharmaceutical Research and Manufacturers of America (PhRMA). [read post]
25 Jun 2020, 2:00 am by HR Daily Advisor Content Team
As pharmaceutical manufacturers work to develop a coronavirus vaccine, the demand for clinical research associates and trial managers has risen by 46%, according to a COVID-19 impact analysis report released by global talent mobility provider Randstad Sourceright. [read post]
15 Jun 2020, 5:13 am by Jean O'Grady
The Products Liability Navigator can assess over 100 product types including the most common: pharmaceutical, medical devices, automotive and consumer products. [read post]
26 May 2020, 6:22 am by Schachtman
PL [Peter Lurie] is with Public Citizen’s Health Research Group. [read post]
23 Apr 2020, 9:02 pm by Joshua Burd
Hyman of the Georgetown University Law Center argued that a prize system would be more fair and more efficient than the current patent system for motivating research in the pharmaceutical industry. [read post]
8 Apr 2020, 9:05 pm by Sophia Gaulkin
The Pharmaceutical Research and Manufacturers of America submitted a comment to the public docket for the proposed rule, demanding that HHS withdraw its proposal. [read post]
9 Mar 2020, 4:42 pm by William Ford
During an exchange with Kadlec, Hawley contended that too many of America’s medical devices, drugs and pharmaceuticals are manufactured in whole or in part overseas. [read post]
9 Mar 2020, 4:42 pm by William Ford
During an exchange with Kadlec, Hawley contended that too many of America’s medical devices, drugs and pharmaceuticals are manufactured in whole or in part overseas. [read post]
29 Feb 2020, 10:50 am by Apsosredesign
With China’s relaxed environmental concerns and lower labor costs, manufacturing some of the ingredients simply is easier to do in China than in America. [read post]
28 Feb 2020, 1:16 pm by Richard Altieri, Benjamin Della Rocca
” At present, cases have been reported in nearly 30 countries, including nations in North America, Europe, Africa and Oceania. [read post]
26 Feb 2020, 2:13 pm by Unknown
“The Act reinvigorated research and development in America, spawning breakthrough discoveries ranging from high-yield crops to advanced medicines. [read post]
10 Feb 2020, 9:05 pm by Marissa Fritz
FDA awarded the manufacturer of Ervebo a tropical disease priority review voucher, allowing the pharmaceutical company to accelerate approval for another drug that would not otherwise qualify for priority review. [read post]
29 Jan 2020, 9:03 pm by Dan Flynn
But yesterday, the bill was allowed to generate a little traction by being included in the Committee on Energy and Commerce’s Subcommittee on Energy’s hearing on “Improving Safety and Transparency in America’s Food and Drugs. [read post]
27 Jan 2020, 5:26 pm by Ben Vernia
 This year, seven drug manufacturers – Actelion Pharmaceuticals US Inc. [read post]
6 Nov 2019, 2:13 am by Dennis Crouch
., 139 S.Ct. 524 (2019) (judicial exceptions to broad statutes are inappropriate)) Pharmaceutical Research and Manufacturers of America (PhRMA) (patent eligibility for diagnostic methods is a critical incentive for advancement in the field). [read post]